# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028641
Filing Date
2021-11-15
Accepted
2021-11-15 16:30:18
Documents
52
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 938864
2 |  | ex31-1.htm | EX-31.1 | 18853
3 |  | ex31-2.htm | EX-31.2 | 18819
4 |  | ex32-1.htm | EX-32.1 | 10659
| Complete submission text file | 0001493152-21-028641.txt |  | 4649494

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | ptix-20210930.xsd | EX-101.SCH | 36067
6 | XBRL CALCULATION FILE | ptix-20210930_cal.xml | EX-101.CAL | 43927
7 | XBRL DEFINITION FILE | ptix-20210930_def.xml | EX-101.DEF | 190391
8 | XBRL LABEL FILE | ptix-20210930_lab.xml | EX-101.LAB | 335719
9 | XBRL PRESENTATION FILE | ptix-20210930_pre.xml | EX-101.PRE | 258705
10 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 666645

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12555 | Film No.: 211411281
SIC: 7389 Services-Business Services, NEC